We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
-1.44%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$40.3B
AUM Growth
-$3.3B
(-7.6%)
Cap. Flow
-$1.89B
Cap. Flow
% of AUM
-4.68%
Top 10 Holdings %
Top 10 Hldgs %
21.18%
Holding
1,160
New
85
Increased
251
Reduced
431
Closed
113
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AVLR
Avalara, Inc.
AVLR
|
+$150M |
| 2 |
EOG Resources
EOG
|
+$128M |
| 3 |
TJX Companies
TJX
|
+$122M |
| 4 |
RTX Corp
RTX
|
+$107M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$105M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$365M |
| 2 |
Burlington
BURL
|
+$216M |
| 3 |
Textron
TXT
|
+$190M |
| 4 |
Dollar Tree
DLTR
|
+$126M |
| 5 |
ExxonMobil
XOM
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.31% |
| 2 | Healthcare | 17.41% |
| 3 | Financials | 15.7% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Industrials | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Entergy
ETR
$50.4B
| $43.5M | 0.11% |
864,404
+50,800
| +6% | +$2.91M |
|
202
Flywire
FLYW
$2.05B
| $43.3M | 0.11% |
1,886,726
-901,485
| -32% | -$21.5M |
|
203
American Express
AXP
$233B
| $43.3M | 0.11% |
321,088
+190,800
| +146% | +$28.9M |
|
204
Diamondback Energy
FANG
$55.9B
| $42.9M | 0.11% |
356,103
+17,300
| +5% | +$2.16M |
|
205
Regeneron Pharmaceuticals
REGN
$78.2B
| $42.9M | 0.11% |
+62,249
| New | +$39.2M |
|
|
MNRL
206
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $42.2M | 0.1% |
1,709,722
+518,821
| +44% | +$13.9M |
|
207
Corteva
CTVA
$50.7B
| $41.8M | 0.1% |
732,137
-21,600
| -3% | -$1.26M |
|
208
Antero Resources
AR
$11.2B
| $41.8M | 0.1% |
1,370,000
-10,000
| -0.7% | -$369K |
|
209
McKesson
MCK
$96.8B
| $41.7M | 0.1% |
122,714
-28,646
| -19% | -$9.94M |
|
210
Marvell Technology
MRVL
$196B
| $41.5M | 0.1% |
968,006
+386,000
| +66% | +$19.1M |
|
211
Cadence Design Systems
CDNS
$93.8B
| $41.5M | 0.1% |
254,000
-3,200
| -1% | -$550K |
|
212
Synopsys
SNPS
$75.1B
| $41.5M | 0.1% |
135,800
-13,600
| -9% | -$4.6M |
|
213
Edwards Lifesciences
EW
$51.1B
| $41.4M | 0.1% |
501,566
-96,000
| -16% | -$9.24M |
|
214
Autodesk
ADSK
$49.6B
| $41.4M | 0.1% |
221,389
+79,800
| +56% | +$16.1M |
|
215
Citizens Financial Group
CFG
$30.7B
| $40.5M | 0.1% |
1,180,019
+634,800
| +116% | +$23.5M |
|
216
Viavi Solutions
VIAV
$9.95B
| $40.4M | 0.1% |
3,096,250
+975,000
| +46% | +$13.9M |
|
217
HCA Healthcare
HCA
$88B
| $40.3M | 0.1% |
219,300
-17,700
| -7% | -$3.53M |
|
218
Illumina
ILMN
$29.9B
| $40.1M | 0.1% |
215,990
+176,302
| +444% | +$34.9M |
|
|
Y
219
DELISTED
Alleghany Corp
Y
| $39.9M | 0.1% |
47,500
| – | – |
|
220
Freeport-McMoran
FCX
$96.7B
| $39.8M | 0.1% |
1,456,900
-52,400
| -3% | -$1.53M |
|
221
Allegion
ALLE
$13.7B
| $39.4M | 0.1% |
+439,471
| New | +$43.5M |
|
222
Moderna
MRNA
$22.8B
| $39.3M | 0.1% |
332,716
+205,258
| +161% | +$31.1M |
|
223
GCM Grosvenor
GCMG
$795M
| $39M | 0.1% |
4,942,786
| – | – |
|
|
NVO
224
Novo Nordisk
NVO
$196B
| $38.7M | 0.1% |
776,540
-221,070
| -22% | -$11.8M |
|
225
Enphase Energy
ENPH
$5.52B
| $38.3M | 0.1% |
138,000
-2,600
| -2% | -$701K |
|
Similar funds
Adage Capital Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Adage Capital Partners held 1,160 positions worth $40.3B, down 7.6% from $43.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners withdrew a net $1.89B in Q3 2022, closing 113 positions and reducing 431 holdings. Its most notable exit was Vonage Holdings Corporation, an estimated $101M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Avalara, Inc. worth $153M.
- Adage Capital Partners's largest Q3 2022 buy was Avalara, Inc.: 1,670,000 shares worth $153M.
- Adage Capital Partners added most to EOG Resources in Q3 2022, an estimated $128M increase.
- Adage Capital Partners's biggest Q3 2022 reduction was Royalty Pharma, cutting an estimated $365M.
- Adage Capital Partners fully exited Vonage Holdings Corporation in Q3 2022, selling an estimated $101M.
- Adage Capital Partners's ten largest holdings make up 21% of its $40.3B portfolio in Q3 2022.
- Adage Capital Partners opened 85 new positions and closed 113 in Q3 2022.
- Adage Capital Partners's portfolio value fell 7.6% quarter-over-quarter to $40.3B.
Based on Adage Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.